In pharmaceutical development, the race to bring medicines to patients faster—without compromising on quality—is more critical than ever. At TAPI, we’re answering that challenge head-on with an innovative platform that transforms how solid forms are identified and developed. By integrating computational tools with high-throughput laboratory automation, we’re not just streamlining solid-state R&D—we’re reshaping it.
Rethinking Polymorph Screening
Solid form matters. Polymorphs, hydrates, solvates, and amorphous structures may influence a drug’s solubility, stability, manufacturability, and regulatory path. Traditionally, uncovering these forms has relied on labor-intensive, trial-and-error methods. Our bespoke platform reimagines this process by combining computational tools modeling with smart experimental design.
We leverage tools like Crystal Structure Prediction (CSP), lattice energy ranking, and targeted screening algorithms to identify different solid forms. Our unique approach allows us to creatively design the experimental plan before we even step into the lab—saving time, materials, and energy.
From Prediction to Precision: Smart Experimentation in Action
Our software-based systems are fully integrated with automated high-throughput polymorph screening (HTPS). This means that parallel experimentation with multiple crystallization conditions can be conducted faster and more systematically than ever before. Using tools like PXRD, DSC, TGA, and microscopy, we can rapidly identify and characterize different solid forms with scientific rigor.
And thanks to a closed-loop feedback system, experimental data feeds back into the AI models—making them smarter over time and improving accuracy with every iteration.
Impact That Scales
This is more than a lab breakthrough—it’s a platform with real-world impact. By enabling earlier identification of optimal solid forms, we help pharmaceutical partners minimize late-stage surprises, improve formulation robustness, and accelerate regulatory submission. It’s a smarter, safer, and faster way to advance drug development.
A New Standard for Solid-State Innovation
At TAPI, science is strength—and our innovative platform embodies our passion for advancing health from the core. By combining digital intelligence with expert intuition, we’re enabling our partners to make better decisions, faster. It’s not just innovation—it’s transformation.
Whether you’re formulating a first-in-class therapy or optimizing a generic molecule, our AI-powered solid form platform is ready to support your journey.
Let’s move beyond what’s expected. Let’s redefine what’s possible.
